Rep. David J. Taylor discloses trade(s) in GOOGL, AMZN, AEP, AMGN, AAPL
David J. Taylor (OH02) disclosed 31 transactions, traded Jan 16 – Jan 29: 19 purchases and 12 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jan 29 | AMZN | - Dave Amazon.com, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | AMGN | - Dave Amgen Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 29 | T | AT&T Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | AVGO | - Dave Broadcom Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | IBP | - Dave Installed Building Products, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | JPM | - Dave JP Morgan Chase & Co. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | MEDP | - Dave Medpace Holdings, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | MSFT | - Dave Microsoft Corporation | Buy | $1,001 - $15,000 | Self |
| Jan 29 | PG | - Dave Procter & Gamble Company | Sell | $1,001 - $15,000 | Self |
| Jan 29 | PLD | - Dave Prologis, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | RPM | - Dave RPM International Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | CRM | - Dave Salesforce, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 29 | VRTX | - Dave Vertex Pharmaceuticals Incorporated | Sell | $1,001 - $15,000 | Self |
| Jan 16 | GOOGL | Alphabet Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | AEP | - Dave American Electric Power Company, Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 16 | AMGN | - Dave Amgen Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 16 | AAPL | - Dave Apple Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 16 | AVGO | - Dave Broadcom Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | ETN | - Dave Eaton Corporation, PLC | Buy | $1,001 - $15,000 | Self |
| Jan 16 | LLY | - Dave Eli Lilly and Company | Sell | $1,001 - $15,000 | Self |
| Jan 16 | HD | - Dave Home Depot, Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | IBP | - Dave Installed Building Products, Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | KR | - Dave Kroger Company | Buy | $1,001 - $15,000 | Self |
| Jan 16 | LRCX | - Dave Lam Research Corporation | Sell | $1,001 - $15,000 | Self |
| Jan 16 | MEDP | - Dave Medpace Holdings, Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | MSFT | - Dave Microsoft Corporation | Buy | $1,001 - $15,000 | Self |
| Jan 16 | PH | - Dave Parker-Hannifin Corporation | Sell | $1,001 - $15,000 | Self |
| Jan 16 | PGR | - Dave Progressive Corporation | Buy | $1,001 - $15,000 | Self |
| Jan 16 | PLD | - Dave Prologis, Inc. | Sell | $1,001 - $15,000 | Self |
| Jan 16 | RPM | - Dave RPM International Inc. | Buy | $1,001 - $15,000 | Self |
| Jan 16 | V | - Dave Visa Inc. | Buy | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY DAVID J. TAYLOR →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. representative has filed a financial disclosure covering stock transactions in five large-cap companies spanning technology, utilities, and healthcare sectors. Congressional stock trading disclosures are public records that can signal legislative priorities or potential conflicts of interest, though individual trades alone do not indicate timing, direction, or rationale. Such filings feed into broader scrutiny of whether lawmakers' portfolios align with their legislative actions or committee assignments.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- David J. TaylorOct 3, 2026View the original filing at the House Clerk ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
UNLIKELYIf media or watchdog scrutiny of the disclosed trades leads to a formal ethics review and subsequent policy action (e.g., stricter trading windows or divestment requirements for Taylor's committee assignments), it could reinforce existing pressure on lawmakers to distance themselves from sector-specific holdings, though the effect on individual equities would likely be negligible.
Left Unattended
LIKELYThe disclosure passes through the standard public filing cycle without triggering investigative coverage or ethics complaints, and the trades remain a routine data point in congressional portfolio tracking with no measurable market consequence.
Escalate
POSSIBLEIf subsequent reporting identifies a pattern of trades that correlate suspiciously with Taylor's committee work or upcoming legislative votes on tech, energy, or pharma regulation, it could amplify existing concerns about insider trading among lawmakers and potentially fuel calls for broader trading restrictions that markets might interpret as regulatory risk for affected sectors.
SPONSORED
Confidence History
- HIGH CONFIDENCEOct 3, 2026 at 6:03 PM
Legally mandated financial disclosure filing -- primary source, not a report about the event